DOP2005000052A - INFUSION PREPARATION INCLUDING ACID (2R) -2-PROPILACTANOIC AS AN ACTIVE INGREDIENT - Google Patents
INFUSION PREPARATION INCLUDING ACID (2R) -2-PROPILACTANOIC AS AN ACTIVE INGREDIENTInfo
- Publication number
- DOP2005000052A DOP2005000052A DO2005000052A DO2005000052A DOP2005000052A DO P2005000052 A DOP2005000052 A DO P2005000052A DO 2005000052 A DO2005000052 A DO 2005000052A DO 2005000052 A DO2005000052 A DO 2005000052A DO P2005000052 A DOP2005000052 A DO P2005000052A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- infusion preparation
- propilactanoic
- active ingredient
- salt
- including acid
- Prior art date
Links
Abstract
La presente invencion se refiere a una preparacion de infusion la cual es útil para enfermedades neurodegenerativas, la cual comprende acido (2R)-2-propiloctanoico o una sal del mismo y un ión metalico basico el cual se suministra a partir de una sal metalica o un hidróxido metàlico de acido débil, preferiblemente de aproximadamente 1 a aproximadamente 5 equivalentes de un ión metalico basico tomando como referencia 1 equivalente de àcido (2R)-2-propiloctanoico o una sal del mismo, y opcionalmente comprende otros componentes de infusion. La preparacion de infusion de la presente invencion tiene un pH apropiado para administración intravenosa, y es útil para administracion intravenosa dado que no requiere ninguna operacion preparatoria tal como disolucion, dilucion o similares en el momento de uso.The present invention relates to an infusion preparation which is useful for neurodegenerative diseases, which comprises (2R) -2-propyloctanoic acid or a salt thereof and a basic metal ion which is supplied from a metal salt or a weak acidic metal hydroxide, preferably from about 1 to about 5 equivalents of a basic metal ion taking as reference 1 equivalent of (2R) -2-propyloctanoic acid or salt thereof, and optionally comprises other infusion components. The infusion preparation of the present invention has an appropriate pH for intravenous administration, and is useful for intravenous administration since it does not require any preparatory operation such as dissolution, dilution or the like at the time of use.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DO2005000052A DOP2005000052A (en) | 2005-03-31 | 2005-03-31 | INFUSION PREPARATION INCLUDING ACID (2R) -2-PROPILACTANOIC AS AN ACTIVE INGREDIENT |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DO2005000052A DOP2005000052A (en) | 2005-03-31 | 2005-03-31 | INFUSION PREPARATION INCLUDING ACID (2R) -2-PROPILACTANOIC AS AN ACTIVE INGREDIENT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2005000052A true DOP2005000052A (en) | 2006-09-30 |
Family
ID=44261466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2005000052A DOP2005000052A (en) | 2005-03-31 | 2005-03-31 | INFUSION PREPARATION INCLUDING ACID (2R) -2-PROPILACTANOIC AS AN ACTIVE INGREDIENT |
Country Status (1)
| Country | Link |
|---|---|
| DO (1) | DOP2005000052A (en) |
-
2005
- 2005-03-31 DO DO2005000052A patent/DOP2005000052A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP066477A (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES ACID (2R) -2-PROPYLOCTANOIC AS AN ACTIVE INGREDIENT | |
| EP4227304A3 (en) | Thiadiazole analogs and their use for treating diseases associated with a deficiency of smn motor neurons | |
| ECSP066476A (en) | PREPARATION OF AN INFUSION THAT INCLUDES ACID (2R) -2-PROPYLOCTANOIC AS ACTIVE INGREDIENT | |
| PH12015502628A1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of disease | |
| MX2015016344A (en) | Imidazopyrrolidinone derivatives and their use in the treatment of disease. | |
| BR112014009031A2 (en) | metal ion stabilized etanercept formulations | |
| CL2011000135A1 (en) | Use of an aqueous pharmaceutical formulation comprising 0.5-10% of terbinafine or a salt thereof, 2-10% of a phospholipid and 1-5% of a surfactant, to prepare a medicament useful for treating a fungal infection; pharmaceutical formulation | |
| AR105712A1 (en) | QUICK ACTION INSULIN COMPOSITIONS | |
| DOP2012000011A (en) | PHARMACEUTICAL FORMULATION | |
| BR112015000229A2 (en) | stable aqueous formulations of etanercept | |
| EP2548552A3 (en) | Titration package for 1-amino-alkylcylohexanes | |
| BR112015029401A8 (en) | pyrazolo-pyrrolidin-4-one derivatives, their uses, and pharmaceutical composition and combination | |
| BR112013022213A2 (en) | parenteral administration of tapentadol | |
| FR2983409B1 (en) | COMPRESSOR CAPABLE OF COMBATTING INJECTION MISTAKE | |
| TNSN07452A1 (en) | Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine | |
| RU2012157473A (en) | METHOD FOR IDENTIFICATION OR TREATMENT OF REACTION "TRANSPLANT AGAINST THE OWNER" | |
| BR112013018938A2 (en) | topical antifungal agent | |
| CL2011000520A1 (en) | Compounds derived from piperazine; use to prepare a useful medication to treat alzheimaer disease, a neurodegenerative disorder and amyloidosis; compound preparation method. | |
| AR039895A1 (en) | COMPOSITION THAT INCLUDES A VITAMIN, A METAL SALT AND AN INSULIN OR A HORMONE OF THE GROWTH AND USE OF SUCH COMPONENTS TO PREPARE IT | |
| AR109012A1 (en) | TRANSDERMAL ADMINISTRATION SYSTEM CONTAINING GALANTAMINE OR SALTS OF THIS | |
| DOP2005000052A (en) | INFUSION PREPARATION INCLUDING ACID (2R) -2-PROPILACTANOIC AS AN ACTIVE INGREDIENT | |
| AR048821A1 (en) | "INFUSION PREPARATION THAT INCLUDES ACID (2R) -2-PROPILOCTANOIC AS AN ACTIVE AND RECENT INGREDIENT" | |
| DOP2005000053A (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES ACID (2R) -2-PROPILACTANOIC AS AN ACTIVE INGREDIENT | |
| AR049015A1 (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES ACID (2R) -2-PROPYLOCTANOIC AS AN ACTIVE INGREDIENT | |
| EA202190247A1 (en) | APPLICATION OF RHC STIMULATORS FOR TREATMENT OF MITOCHONDRIAL DISEASES |